BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf ...


        BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) investors concerning the Company’s possible violations of federal securities laws.



On May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million, citing "increased use of MIS Osteotomy solutions and more competition from knockoffs of [the Company’s] Lapiplasty products."

On this news, Treace's stock price fell $6.95, or 62.5%, to close at $4.17 per share on May 8, 2024, thereby injuring investors.

If you purchased Treace securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

        
      

TMCI

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors

Treace Medical faces an investigation for possible securities law violations.
The company lowered its 2024 guidance by $20 million due to competition.
Treace's stock plummeted 62.5% following the disappointing financial results.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News